ContactISSN:e-ISSN: 2757-976X
Author Sign-inReviewer Sign-inRegister
TürkçeEnglish
Home
About Journal
Copyright NoticeOpen Access PolicyAim and ScopePrinciples of ArbitrationReviewer and Editor GuideFee PolicyEthical Principles and Publication PolicyArchiving PolicyIndexing
Information For AuthorsEditorial BoardSend ArticleLatest IssueArchiveContact Us

RETROSPECTIVE EVALUATION OF ANKLE-BRACHIAL INDEX AND FRAMINGHAM RISK SCORES IN INDIVIDUALS UNDERGOING PERIODIC HEALTH EXAMINATION

Ahmet Öksüz,RUHUŞEN KUTLU

  • RUHUŞEN KUTLU: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  •  Year : 2025
  •  Vol : 5
  •  Issue : 3
  •  Page : 93-100
Objective: The Ankle-Brachial Index (ABI) serves as an indicator for the diagnosis of peripheral arterial disease and general atherosclerosis. Framingham risk score (FRS) is among the validated measures used to evaluate 10-year cardiovascular risk. This study aimed to assess the ABI and FRS in patients who presented outpatient clinic for periodic health examinations. Methods: This retrospective study examined the medical files of 580 patients aged ≥18 who presented to the Family Medicine outpatient clinic between June 25, 2013, and June 25, 2016, for any reason. The FRS was calculated automatically using a computer-based tool. Two distinct FRS values, FRS1 (LDL-based) and FRS2 (total cholesterol-based), were generated by utilizing both LDL cholesterol and total cholesterol levels. The ABI was calculated as the ratio of ankle systolic blood pressure to brachial systolic blood pressure. Results: Of the 580 patients, 58.3% (n=338) were female, and 41.7% (n=242) were male. The mean value of ABI in our study was 1.13±0.10. A low ABI (≤0.97) was identified in 15 patients (2.6%). A statistically significant association was determined between ABI and both FRS1 and FRS2 (p<0.001, p<0.001). A statistically significant relationship was found between FRS1 and Body Mass Index (BMI) (p=0.002). A comparison of FRS1 and FRS2 by gender demonstrated a significantly higher cardiovascular risk in men than in women (p<0.001). Conclusion: The current study determined that the risk of coronary artery disease (CAD) was significantly higher in individuals with ABI ≤0.97 compared to those with ABI >0.97. The findings of this study demonstrated that the ABI score with FRS can be utilized as a cost-effective and effective marker for assessing cardiovascular risk during periodic health examinations in primary care within our country.
Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2025, Vol5, Issue3
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :

References

  1. 1. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Müdürlüğü. Aile Hekimliği Uygulamasında Önerilen Periyodik Sağlık Muayeneleri ve Tarama Testleri; 2015. Available from: https://hsgm.saglik.gov.tr/depo/birimler/kronik-hastaliklar-ve-yasli-sagligi-db/Dokumanlar/Kitaplar/Periyodik_Muayene_Rehberi.pdf. Accessed 2024 Dec 31.
  2. 2. Kaplan Ş, Çelik Ş. Koroner kollateral gelişimi ile endotel fonksiyonları arasındaki ilişki. Selçuk Tıp Derg. 2014;30(4):150–2.
  3. 3. Onat A, Uğur M, Tuncer M, Ayhan E, Kaya Z, Küçükdurmaz Z, et al. Age at death in the Turkish Adult Risk Factor Study: Temporal trend and regional distribution at 56,700 person-years’ follow-up. Turk Kardiyol Dern Ars. 2009;37:155–60.
  4. 4. Demirören N, Akın B, Benli S. Bir aile sağlığı merkezinde yetişkin bireylerde kan basıncı yüksekliğinin ve ilişkili risk faktörlerinin belirlenmesi. Genel Sağlık Bilimleri Dergisi. 2020;1(2):34–47.
  5. 5. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76:2982–3021. doi:10.1016/j.jacc.2020.11.010.
  6. 6. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837–45. doi:10.1161/01.CIR.88.3.837.
  7. 7. Şatıroğlu Ö, Bostan M, Çiçek Y, Çetin M, Bozkurt M. Periferik arter hastalığı yaygınlığıyla aterosklerotik risk faktörleri arasında ilişki. Selçuk Tıp Derg. 2011;27(4):213–8.
  8. 8. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis. JAMA. 2008;300:197–208. doi:10.1001/jama.300.2.197.
  9. 9. Miura T, Minamisawa M, Ueki Y, Abe N, Nishimura H, Hashizume N, et al. Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study. PLoS One. 2017;12:e0177609. doi:10.1371/journal.pone.0177609.
  10. 10. Welten GM, Schouten O, Chonchol M, Hoeks SE, Bax JJ, Van Domburg RT, et al. Prognosis of patients with peripheral arterial disease. J Cardiovasc Surg (Torino). 2009;50:109–21.
  11. 11. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579.
  12. 12. Ouriel K, Zarins CK. Doppler ankle pressure: An evaluation of three methods of expression. Arch Surg. 1982;117(10):1297–300. doi:10.1001/archsurg.1982.01380340051010.
  13. 13. Van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: The Rotterdam Study. Circulation. 2004;109:1089–94. doi:10.1161/01.CIR.0000118493.65643.9F.
  14. 14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. PMID: 12485966.
  15. 15. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9 Suppl 4:228S–33S. doi:10.1038/oby.2001.123.
  16. 16. Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg. 2009;38:305–11. doi:10.1016/j.ejvs.2009.04.029.
  17. 17. Peltonen E, Laivuori M, Vakhitov D, Korhonen P, Venermo M, Hakovirta H. The cardiovascular-mortality-based estimate for normal range of the ankle–brachial index (ABI). J Cardiovasc Dev Dis. 2022;9(5):147. doi:10.3390/jcdd9050147.
  18. 18. Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2000;86:615–8. doi:10.1016/S0002-9149(00)01065-0.
  19. 19. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol. 2005;25:1463–9. doi:10.1161/01.ATV.0000178992.05726.5d.
  20. 20. Karabay Ö, Karaçelik M, Yıllık L, Tekin N, İriz AB, Kumdereli S, et al. Ischemic peripheral arterial disease: A screening survey. Turk Gogus Kalp Damar Cerrahisi Derg. 2012;20:450–7.
  21. 21. Çelik HH, Kutlu R, Çivi S. Is ankle brachial index and Framingham risk score a predictor of cardiovascular diseases in people aged ≥50 years? Turk J Geriatr. 2013;16(2):142–9.
  22. 22. Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, et al. Ethnicity and peripheral arterial disease: The San Diego Population Study. Circulation. 2005;112(17):2703–7. doi:10.1161/CIRCULATIONAHA.105.542290.
  23. 23. Tsai WC, Lee WH, Chen YC, et al. Combination of low ankle-brachial index and high ankle-brachial index difference for mortality prediction. Hypertens Res. 2021;44:850–7. doi:10.1038/s41440-021-00636-y.
  24. 24. Sözmen K, Ünal B. Prevalence of low ankle-brachial index and relationship with cardiovascular risk factors in a Western urban population in Turkey. Angiology. 2014;65(1):43–50. doi:10.1177/0003319712463848.
  25. 25. Velescu A, Clara A, Peñafiel J, Ramos R, Marti R, Grau M, et al. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events: The REGICOR study. Atherosclerosis. 2015;241(2):357–63. doi:10.1016/j.atherosclerosis.2015.05.017.
  26. 26. Tanaka S, Kaneko H, Kano H, Matsuno S, Suzuki S, Takai H, et al. The predictive value of the borderline ankle-brachial index for long-term clinical outcomes: An observational cohort study. Atherosclerosis. 2016;250:69–76. doi:10.1016/j.atherosclerosis.2016.05.014.
  27. 27. O’Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: Results from the Cardiovascular Health Study. Circulation. 2006;113:388–93. doi:10.1161/CIRCULATIONAHA.105.580308.
  28. 28. Noel SE, Cornell DJ, Zhang X, Mirochnick JC, Mattei J, Falcon LM, et al. Patterns of change in cardiovascular risk assessments and ankle brachial index among Puerto Rican adults. PLoS One. 2021;16(1):e0245236. doi:10.1371/journal.pone.0245236.
  29. 29. Gašparini D, Zuljani A, Wensveen FM, Turk Wensveen T. A cross-sectional study in type 2 diabetes patients reveals that elevated pulse wave velocity predicts asymptomatic peripheral arterial disease associated with age and diabetes duration. Int J Cardiol Heart Vasc. 2023 Nov 26;49:101308. doi: 10.1016/j.ijcha.2023.101308.